ArticleCancers2024

Discovery, Validation and Mechanistic Study of XPO1 Inhibition in the Treatment of Triple-Negative Breast Cancer.

Amy L Paulson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.